Search

Your search keyword '"Sansotta G"' showing total 70 results
Start Over Author "Sansotta G" Publication Year Range Last 50 years
70 results on '"Sansotta G"'

2. Radiation therapy utilisation in patients with bone metastases secondary to prostate cancer: A multicenter study

Author

Mazzei, M.M., primary, Sindoni, A., additional, Santacaterina, A., additional, Platania, A., additional, Marino, L., additional, Umina, V., additional, Girlando, A., additional, Ricottone, N., additional, D'Agostino, A., additional, Marletta, F., additional, Tamburo, M., additional, Acquaviva, G., additional, Spatola, C., additional, Privitera, G., additional, Frosina, P., additional, Garufi, G., additional, Bonanno, S., additional, Rosso, A., additional, Barone, V., additional, Corallo, A., additional, Sansotta, G., additional, Delia, P., additional, Donato, V., additional, Lopes, S., additional, Pisana, M., additional, Runco, R., additional, Risoleti, E., additional, Arcudi, A., additional, Rifatto, C., additional, Arena, G., additional, Potami, A., additional, Messina, G., additional, Parisi, S., additional, Marletta, D., additional, Pontoriero, A., additional, Iatì, G., additional, and Pergolizzi, S., additional

Published
2017
Full Text
View/download PDF

3. IGRT and Robotic Technology for new advanced Radiation Therapy. One year of experience with the Cyberknife® Robotic Radiosurgery System for treatment of intracranial and extracranial lesions

Author

Pontoriero A., Conti A., Frosina P., Sansotta G., Spagna R., Ielo D., Midili F., Tomasello F., De Renzis C. ., Pontoriero A., Conti A., Frosina P., Sansotta G., Spagna R., Ielo D., Midili F., Tomasello F., and De Renzis C. .

Subjects
Cyberknife®, Radiation Therapy, Radio-surgery, IGRT
Published
2008

4. Breast cancer bone metastases: an epidemiologic study in selected radiation departments

Author

Runco, R., Laganà, S., Marino, G., Di Grazia, A., Marino, L., Umina, V., Girlando, A., Ricottone, N., D Agostino, A., Marletta, F., Tamburo, M., Corsaro, G., Rallo, F., Santacaterina, A., Acquaviva, G., Crispi, M., Palazzolo, C., Platania, A., Spatola, C., Privitera, G., Frosina, P., Garufi, G., Bonanno, S., Rosso, A., Barone, V., Corallo, A., Sansotta, G., Delia, P., Donato, V., Lopes, S., Pisana, M., Borzí, F., Iatí, G., Potami, A., Messina, G., Parisi, S., Frosina, L., Marletta, D., Renzis, C., Pontoriero, A., and Stefano Pergolizzi

Subjects
Adult, Incidence, Prevalence, Humans, Bone Neoplasms, Breast Neoplasms, Female, Middle Aged, Sicily, Aged, Retrospective Studies
Abstract

To quantify radiation treatments for bone metastases from breast cancer in three Sicilian provinces (Messina, Catania, Ragusa) with respect to the general population and the incidence and prevalence of breast cancer in this macro-area in a 8-year period.All bone metastasis patients treated using radiotherapy in 8 radiation departments operating in the provinces of Messina, Catania and Ragusa were collected. Among these, metastases from breast carcinoma were analyzed according to year of irradiation. An analysis of breast cancer incidence and prevalence with respect to inhabitants in this macro-area was conducted using literature and census data.From January 2004 to December 2011, irradiation was delivered in 4419 bone metastasis patients. Among these, 1617 had a primary breast cancer with a median treatment per year of 206.5 (range, 164-251); 211 patients were treated in 2004 and 206 in 2011. In 2004, there were 1,048,957 female residents in the three provinces and 1,065,422 in 2011. The reported breast cancer incidence and prevalence in Sicily was respectively 100.79/100,000 and 908.54/100,000 in 2004 and 108.41/100,000 and 1091.29/100,000 in 2010.There has been an increase in both incidence and prevalence of breast cancer in Sicily. Nevertheless, it seems that there was no increment in skeletal-related events requiring irradiation in such patients in eastern Sicily radiation departments.

Published
2014

6. SALIVARY GLANDS IRRADIATION INHEAD&NECK CARCINOMA ANDOROPHARYNGEAL MYCOSIS. A POSSIBLERELATIONSHIP? ANSWERS FROM MIR(MYCOSIS IN RADIOTHERAPY) STUDY ONPROGNOSTIC FACTORS

Author

Busetto, M., Fusco, V., Pavanato, G., Maggio, F., Corbella, F., Bonetti, B., Orsatti, M., Panizzoni, G., DE RENZIS, Costantino, Montemaggi, P., Cionini, L., Loreggian, L., Lastrucci, L., Castaldo, G., Colombo, S., Mandoliti, G., Berlinghieri, S., Guglielmi, R. B., Sansotta, G., Sciumé, F., Antonello, M., Matteucci, F., Delia, P., Sotti, G., Frata, P., Turcato, G., and Bolzan, M.

Published
2011

13. INFLUENZA DELLA MICOSI OROFARINGEA SULLA TOLLERANZA DEI TESSUTI SANI IN CORSO DI RT PER CANCRO DEL CAPOCOLLO.PRIMI RISULTATI DELLO STUDIO MIR (MICOSI IN RADIOTERAPIA) SUI FATTORI PROGNOSTICI

Author

Busetto, M., Fusco, V., Pavanato, G., Maggio, F., Corbella, F., Bonetti, B., Orsatti, M., Panizzoni, G., DE RENZIS, Costantino, Montemaggi, P., Cionini, L., Loreggian, L., Lastrucci, L., Castaldo, G., Colombo, S., Mandoliti, G., Berlinghieri, S., Guglielmi, R. B., Sansotta, G., Sciumé, F., Antonello, M., Matteucci, F., Delia, P., Sotti, G., Frata, P., Turcato, G., and Bolzan, M.

Published
2010

17. GESTIONE DEL RISCHIO DI MICOSI IN CORSO DI TRATTAMENTI INTEGRATI O RADIOTERAPIA ESCLUSIVA PER CARCINOMI DEL CAPO-COLLO. RISULTATI PRELIMINARI DELLO STUDIO MIR (MICOSI IN RADIOTERAPIA) SUI FATTORI PROGNOSTICI

Author

Busetto, M., Fusco, V., Corbella, F., Pavanato, G., Bonetti, B., Orsatti, M., Panizzoni, G., DE RENZIS, Costantino, Montemaggi, P., Cionini, L., Loreggian, L., Lastrucci, L., Castaldo, G., Colombo, S., Mandoliti, G., Berlinghieri, S., Maggio, F., Guglielmi, R. B., Sansotta, G., Sciumé, F., Antonello, M., Matteucci, F., Delia, P., Sotti, G., Frata, P., Turcato, G., Pizzi, G. B., and Bolzan, M.

Published
2009

18. Risk management of mycosis during integrated or exclusive radiotherapy for head and neck cancer. Preliminary results of MIR (Mycosis In Radiotherapy) study on prognostic factors

Author

Busetto, M, Fusco, V, Corbella, F, Pavanato, G, Bonetti, B, Orsatti, M, Panizzoni, G, DE RENZIS, C, Montemaggi, P, Cionici, L, Loreggian, L, Lastrucci, L, Castaldo, G, Colombo, S, Mandoliti, G, Berlinghieri, S, Maggio, F, Guglielmi, Rb, Sansotta, G, Sciume', F, Antonello, M, Matteucci, F, Delia, P, Sotti, G, Frata, Paolo, Turcato, G, Pizzi, Gb, and Bolzan, M.

Published
2009

24. Use of probiotics for prevention of radiation-induced diarrhea

Author

Delia, P., Sansotta, G., Donato, Valentino, Frosina, Pasquale, Salatino, A., Messina, G., DE RENZIS, Costantino, and Famularo, G.

Subjects
Diarrhea, Gastrointestinal Diseases, Neoplasms, Premedication, Probiotics, Humans, Radiotherapy, Adjuvant, Bacterial Infections
Published
2007

45. Radiation-induced emesis: A prospective observational multicenter Italian trial

Author

Maranzano, E, Latini, P, Roila, F, De Angelis, V, Tonato, M, Ballatori, E, Del Favero, A, Ciccarese, G, Palladino, Ma, Galardi, A, Cintolesi, V, Sulprizio, S, Biti, G, Dessi, M, Maxia, G, Lupattelli, M, Piro, F, Bellavita, R, Bianchi, P, Timurian, D, Dal Fior, S, Iannone, T, Bonanno, I, Magno, L, Fillini, C, Marchetti, G, Giudici, S, Corvo, R, Mignogna, M, Sargenti, A, DE RENZIS, Costantino, Sansotta, G, Di Russo, A, Ricci, Sb, Sciume, F, Liotta, P, Del Duca, M, Emiliani, E, Morganti, Ag, Cellini, N, Mandoliti, G, Polico, C, Trippa, F, Checcaglini, F, Sola, B, Trotti, Ab, Ponticelli, P, Lombardi, R, Sarti, E, Moro, G, Iacopino, B, Galuppi, A, Palmucci, T, La Monica MM, Leggio, M, Lonardi, F, Marzi, M, Di Marco, A, Pergolizzi, Stefano, Pizzi, G, Cerrotta, A, Orecchia, R, Barsacchi, L, Silvestro, G, Scoppa, G, Franchini, P, Vanzo, C, Cristallini, S, D'Abbiero, N, Salvi, G, Tombolini, V, Parisi, S, Alfieri, M, Sebaste, L, Malinverni, G., Tomio, L, Buffoli, A, and Pradella, R.

Published
1999

48. Palliative treatment in neoplastic jaundice. Personal experience

Author

Giuseppa GIACOBBE, Pollicino A, Sansotta G, Ma, Gioffrè Florio, and Familiari L

Subjects
Aged, 80 and over, Male, Pancreatic Neoplasms, Ampulla of Vater, Common Bile Duct Neoplasms, Palliative Care, Drainage, Humans, Jaundice, Endoscopy, Female, Middle Aged, Aged
Abstract

The palliative treatment of biliary duct neoplastic obstruction represents a problem of great importance and frequently can't leave out of consideration patients clinical conditions and phase of neoplastic disease. Authors, in this article refers their experience on palliative treatment of neoplastic jaundice and indications for surgical or endoscopic treatment. Their experience shows that surgical palliation must be performed in patients with preoperative instrumental investigations without "surgical risk", this vouches for a better quality of life than endoscopic procedure performed with diffuse neoplastic disease and in patients with surgical risk.

Published
1991

50. Clinical Evaluation of Low-Molecular-Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial.

Author

Delia P, Sansotta G, Pontoriero A, Iati G, De Salvo S, Pisana M, Potami A, Lopes S, Messina G, and Pergolizzi S

Subjects
Adult, Aged, Female, Humans, Middle Aged, Neoplasm Staging, Radiation Injuries prevention & control, Radiotherapy, Adjuvant, Uterine Cervical Neoplasms therapy, Vaginal Diseases etiology, Hyaluronic Acid administration & dosage, Uterine Cervical Neoplasms radiotherapy, Vaginal Diseases prevention & control
Abstract

Background: Radiotherapy treatment for cervical cancer (CC) often induces side effects, including inflammation, dryness, dyspareunia. Considering its key role in the healing process, hyaluronic acid (HA) could be useful for the completion of radiotherapy., Objectives: The aim of this work was to evaluate the ability of HA to reduce the onset of side effects due to radiotherapy., Materials and Methods: In total, 180 women undergoing radiotherapy were randomized into two arms: controls and those treated with vaginal suppositories containing low-molecular-weight HA from day 1 of radiotherapy. The study lasted 5 weeks and was characterized by three visits: at baseline (T0), 15 days later (T1), and at the end of the radiotherapy cycle (T2). The onset of side effects, pain, safety, efficacy, acceptability of treatment, and compliance to the therapy were evaluated., Results: Patients in the control arm reported the onset and worsening of all symptoms with a moderate or severe grade at T2, whereas in the treatment arm almost 90% of patients reported the absence of symptoms or a mild grade. All patients in the treatment arm referred a lower intensity of pain on a visual analog scale compared with the control arm at T2 (6.85 ± 0.94 vs. 1.88 ± 1.02)., Conclusions: HA was able to help vaginal mucosa healing during radiotherapy in patients with CC., (© 2019 S. Karger AG, Basel.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results